Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Medical Marijuana Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Medical Marijuana Market Status and Forecast (2016-2027)
      • 1.3.2 Global Medical Marijuana Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Medical Marijuana Supply by Company

    • 2.1 Global Medical Marijuana Sales Volume by Company
    • 2.2 Global Medical Marijuana Sales Value by Company
    • 2.3 Global Medical Marijuana Price by Company
    • 2.4 Medical Marijuana Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Medical Marijuana Market Status by Category

    • 3.1 Medical Marijuana Category Introduction
      • 3.1.1 Dried Flower
      • 3.1.2 Oils + Concentrates
      • 3.1.3 Softgel Capsules
    • 3.2 Global Medical Marijuana Market by Category
      • 3.2.1 Global Medical Marijuana Sales Volume by Category (2016-2021)
      • 3.2.2 Global Medical Marijuana Sales Value by Category (2016-2021)
      • 3.2.3 Global Medical Marijuana Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Medical Marijuana Market Status by End User/Segment

    • 4.1 Medical Marijuana Segment by End User/Segment
      • 4.1.1 Muscle Spasms
      • 4.1.2 Nausea (from cancer chemotherapy)
      • 4.1.3 Chronic Illness (HIV/Nerve Pain)
      • 4.1.4 Seizure Disorders
      • 4.1.5 Crohn's Disease
    • 4.2 Global Medical Marijuana Market by End User/Segment
      • 4.2.1 Global Medical Marijuana Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Medical Marijuana Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Medical Marijuana Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Medical Marijuana Market Status by Region

    • 5.1 Global Medical Marijuana Market by Region
      • 5.1.1 Global Medical Marijuana Sales Volume by Region
      • 5.1.2 Global Medical Marijuana Sales Value by Region
    • 5.2 North America Medical Marijuana Market Status
    • 5.3 Europe Medical Marijuana Market Status
    • 5.4 Asia Pacific Medical Marijuana Market Status
    • 5.5 Central & South America Medical Marijuana Market Status
    • 5.6 Middle East & Africa Medical Marijuana Market Status

    6 North America Medical Marijuana Market Status

    • 6.1 North America Medical Marijuana Market by Country
      • 6.1.1 North America Medical Marijuana Sales Volume by Country (2016-2021)
      • 6.1.2 North America Medical Marijuana Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Medical Marijuana Market Status

    • 7.1 Europe Medical Marijuana Market by Country
      • 7.1.1 Europe Medical Marijuana Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Medical Marijuana Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Medical Marijuana Market Status

    • 8.1 Asia Pacific Medical Marijuana Market by Country
      • 8.1.1 Asia Pacific Medical Marijuana Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Medical Marijuana Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Medical Marijuana Market Status

    • 9.1 Central & South America Medical Marijuana Market by Country
      • 9.1.1 Central & South America Medical Marijuana Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Medical Marijuana Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Medical Marijuana Market Status

    • 10.1 Middle East & Africa Medical Marijuana Market by Country
      • 10.1.1 Middle East & Africa Medical Marijuana Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Medical Marijuana Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Medical Marijuana Manufacturing Cost Analysis
    • 11.5 Medical Marijuana Sales Channel and Distributors Analysis
      • 11.5.1 Medical Marijuana Sales Channel
      • 11.5.2 Medical Marijuana Distributors
    • 11.6 Medical Marijuana Downstream Major Buyers

    12 Global Medical Marijuana Market Forecast by Category and by End User/Segment

    • 12.1 Global Medical Marijuana Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Medical Marijuana Forecast by Category
      • 12.2.1 Global Medical Marijuana Sales Volume Forecast by Category
      • 12.2.2 Global Medical Marijuana Sales Value Forecast by Category
      • 12.2.3 Global Medical Marijuana Price Forecast by Category
    • 12.3 Global Medical Marijuana Forecast by End User/Segment
      • 12.3.1 Global Medical Marijuana Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Medical Marijuana Sales Value Forecast by End User/Segment
      • 12.3.3 Global Medical Marijuana Price Forecast by End User/Segment

    13 Global Medical Marijuana Market Forecast by Region/Country

    • 13.1 Global Medical Marijuana Market Forecast by Region (2022-2027)
      • 13.1.1 Global Medical Marijuana Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Medical Marijuana Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Sprott
      • 14.1.1 Company Information
      • 14.1.2 Medical Marijuana Product Introduction
      • 14.1.3 Sprott Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Scotts Miracle-Gro
      • 14.2.1 Company Information
      • 14.2.2 Medical Marijuana Product Introduction
      • 14.2.3 Scotts Miracle-Gro Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 MedReLeaf
      • 14.3.1 Company Information
      • 14.3.2 Medical Marijuana Product Introduction
      • 14.3.3 MedReLeaf Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Insys Therapeutics
      • 14.4.1 Company Information
      • 14.4.2 Medical Marijuana Product Introduction
      • 14.4.3 Insys Therapeutics Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Horizons Marijuana Life Sciences Index ETF
      • 14.5.1 Company Information
      • 14.5.2 Medical Marijuana Product Introduction
      • 14.5.3 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 GW Pharmaceuticals
      • 14.6.1 Company Information
      • 14.6.2 Medical Marijuana Product Introduction
      • 14.6.3 GW Pharmaceuticals Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Canopy Growth
      • 14.7.1 Company Information
      • 14.7.2 Medical Marijuana Product Introduction
      • 14.7.3 Canopy Growth Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 CanniMed Therapeutics
      • 14.8.1 Company Information
      • 14.8.2 Medical Marijuana Product Introduction
      • 14.8.3 CanniMed Therapeutics Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Aurora Cannabis
      • 14.9.1 Company Information
      • 14.9.2 Medical Marijuana Product Introduction
      • 14.9.3 Aurora Cannabis Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Aphria
      • 14.10.1 Company Information
      • 14.10.2 Medical Marijuana Product Introduction
      • 14.10.3 Aphria Medical Marijuana Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Medical Marijuana market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Medical Marijuana market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Dried Flower
      Oils + Concentrates
      Softgel Capsules

      Segmented by End User/Segment
      Muscle Spasms
      Nausea (from cancer chemotherapy)
      Chronic Illness (HIV/Nerve Pain)
      Seizure Disorders
      Crohn's Disease

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sprott
      Scotts Miracle-Gro
      MedReLeaf
      Insys Therapeutics
      Horizons Marijuana Life Sciences Index ETF
      GW Pharmaceuticals
      Canopy Growth
      CanniMed Therapeutics
      Aurora Cannabis
      Aphria

      Buy now